Baudax Bio to Report First Quarter 2021 Financial Results

Baudax Bio, Inc.

MALVERN, PA — Baudax Bio, Inc. (Nasdaq: BXRX) announced that it will report first quarter 2021 financial results on Wednesday, May 5, 2021. Baudax Bio’s management team will host a conference call and webcast at 8:00 a.m. ET on Wednesday, May 5, 2021, to discuss the financial results and recent operational highlights.

To access the conference call please dial (866) 220-5595 (local) or (615) 622-8062 (international) at least 10 minutes prior to the start time and refer to conference ID 5444429. A live audio webcast of the call will be available under “Events” in the Investor section of the Company’s website, An archived webcast will be available on the Company’s website approximately two hours after the event and will be available for 30 days.

Headquartered in Malvern, PA, Baudax Bio, Inc. is, a pharmaceutical company focused on developing and commercializing innovative products for acute care settings.

READ:  Zynerba Pharmaceuticals Reports First Quarter 2021 Financial Results

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Disclosure: This site contains affiliate links to products, identified by the Affiliate Disclosure icon. MyChesCo may receive a commission for purchases made through these links.

Buy Us a Cup of Coffee
Notify of
Inline Feedbacks
View all comments